Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.
Related Research units
Bibliographical data
Original language | English |
---|---|
Article number | 8 |
ISSN | 0887-6924 |
Publication status | Published - 2011 |
pubmed | 21494258 |
---|